Raymond James & Associates’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,217
| Closed | -$38K | – | 3636 |
|
|
2018
Q3 | $38K | Sell |
11,217
-1,454
| -11% | -$4.93K | ﹤0.01% | 3449 |
|
|
2018
Q2 | $48K | Buy |
12,671
+500
| +4% | +$1.89K | ﹤0.01% | 3398 |
|
|
2018
Q1 | $50K | Sell |
12,171
-3,216
| -21% | -$13.2K | ﹤0.01% | 3282 |
|
|
2017
Q4 | $72K | Buy |
15,387
+1,615
| +12% | +$7.56K | ﹤0.01% | 3199 |
|
|
2017
Q3 | $98K | Sell |
13,772
-719
| -5% | -$5.12K | ﹤0.01% | 3143 |
|
|
2017
Q2 | $105K | Sell |
14,491
-10,410
| -42% | -$75.4K | ﹤0.01% | 3068 |
|
|
2017
Q1 | $153K | Buy |
24,901
+12,996
| +109% | +$79.9K | ﹤0.01% | 2966 |
|
|
2016
Q4 | $70K | Sell |
11,905
-2,537
| -18% | -$14.9K | ﹤0.01% | 3007 |
|
|
2016
Q3 | $77K | Buy |
14,442
+2,128
| +17% | +$11.3K | ﹤0.01% | 2981 |
|
|
2016
Q2 | $82K | Sell |
12,314
-212
| -2% | -$1.41K | ﹤0.01% | 2813 |
|
|
2016
Q1 | $58K | Buy |
+12,526
| New | +$58K | ﹤0.01% | 2745 |
|
|
2015
Q2 | – | Sell |
-19,624
| Closed | -$250K | – | 2469 |
|
|
2015
Q1 | $250K | Buy |
19,624
+2,235
| +13% | +$28.5K | ﹤0.01% | 2254 |
|
|
2014
Q4 | $246K | Buy |
+17,389
| New | +$246K | ﹤0.01% | 2167 |
|